News

Establishment Labs is a small-cap medical device company achieving revenue growth and projecting reductions in operating ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
A federal judge in Texas has blocked the FDA’s plans to bring laboratory-developed tests ... medical devices under the Federal Food, Drug & Cosmetic Act, which grants the FDA its regulatory ...
Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug discoveries, is pleased to announce the successful ...
The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...
The Maharashtra Authority for Advance Ruling (AAR) has determined that the cancer prognostic and diagnostic services provided ...
Commercial space station developer Vast has signed three more payload customers for its Haven-1 station set to launch in a ...
Homegrown beauty brand Juana is redefining skincare from the Middle East to the rest of the world, with advanced formulas and ...
As topicals, aesthetics services and medicine converge, dermocosmetics is taking skin care in new bold directions.
One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but Congress could still take on the issue.
After biotech company Colossal announced the birth of three pups bearing the DNA signatures of dire wolves, a predator last seen roaming over 10,000 years ago, curiosity has emerged as to how they did ...
Colossal’s dire wolf project is not a resurrection – it is an imitation. But that doesn’t mean it lacks value. It offers a ...